Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$2.92 - $5.33 $542,340 - $989,956
-185,733 Reduced 65.49%
97,888 $286,000
Q1 2024

May 14, 2024

SELL
$3.27 - $5.65 $1.11 Million - $1.92 Million
-339,252 Reduced 54.47%
283,621 $1.6 Million
Q4 2023

Feb 14, 2024

SELL
$2.07 - $4.54 $3.89 Million - $8.53 Million
-1,878,803 Reduced 75.1%
622,873 $2.67 Million
Q3 2023

Nov 14, 2023

BUY
$3.29 - $4.9 $1.83 Million - $2.72 Million
555,016 Added 28.51%
2,501,676 $8.68 Million
Q2 2023

Aug 14, 2023

BUY
$4.25 - $5.88 $3.4 Million - $4.71 Million
800,874 Added 69.9%
1,946,660 $9.05 Million
Q1 2023

May 15, 2023

SELL
$4.48 - $8.45 $2.05 Million - $3.87 Million
-458,443 Reduced 28.58%
1,145,786 $5.29 Million
Q4 2022

Feb 14, 2023

BUY
$5.41 - $8.08 $1.89 Million - $2.83 Million
350,124 Added 27.92%
1,604,229 $13 Million
Q3 2022

Nov 14, 2022

BUY
$5.17 - $7.11 $2.74 Million - $3.76 Million
529,024 Added 72.96%
1,254,105 $6.96 Million
Q2 2022

Aug 15, 2022

BUY
$3.41 - $8.95 $2.47 Million - $6.49 Million
725,081 New
725,081 $3.78 Million
Q1 2022

May 13, 2022

SELL
$7.78 - $15.31 $1.44 Million - $2.83 Million
-184,765 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$14.25 - $23.53 $310,051 - $511,965
21,758 Added 13.35%
184,765 $2.75 Million
Q3 2021

Nov 15, 2021

BUY
$16.88 - $22.38 $990,636 - $1.31 Million
58,687 Added 56.26%
163,007 $3.08 Million
Q2 2021

Aug 16, 2021

SELL
$18.03 - $23.82 $6.62 Million - $8.74 Million
-367,012 Reduced 77.87%
104,320 $1.94 Million
Q1 2021

May 18, 2021

BUY
$20.29 - $27.54 $2.95 Million - $4.01 Million
145,567 Added 44.68%
471,332 $10.7 Million
Q4 2020

Feb 16, 2021

BUY
$10.16 - $23.98 $1.22 Million - $2.88 Million
120,067 Added 58.37%
325,765 $7.07 Million
Q3 2020

Nov 16, 2020

BUY
$7.44 - $13.15 $1.53 Million - $2.7 Million
205,698 New
205,698 $2.07 Million

Others Institutions Holding STRO

About SUTRO BIOPHARMA, INC.


  • Ticker STRO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,161,500
  • Market Cap $139M
  • Description
  • Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...
More about STRO
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.